Efficacy and safety of oral compared with intravenous tranexamic acid in reducing blood loss after primary total knee and hip arthroplasty: a meta-analysis

BACKGROUND: Tranexamic acid (TXA) is an anti-fibrinolytic agent successfully preventing blood loss when using intravenously (IV) in total hip arthroplasty (THA) and total knee arthroplasty (TKA). An oral administration, which is available on blood sparing, has been reported exhibit profound cost-sav...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xiaozhen, Gong, Guiqing, Han, Naili, Liu, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278110/
https://www.ncbi.nlm.nih.gov/pubmed/30509227
http://dx.doi.org/10.1186/s12891-018-2358-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278110/
https://www.ncbi.nlm.nih.gov/pubmed/30509227
http://dx.doi.org/10.1186/s12891-018-2358-2

Ejemplares similares